Literature DB >> 21830398

Co-existence of gastrointestinal stromal tumors with other primary neoplasms.

Alper Sevinc1, Mesut Seker, Ahmet Bilici, Nuriye Yildirim Ozdemir, Ramazan Yildiz, Basak Oven Ustaalioglu, Mehmet Emin Kalender, Faysal Dane, Halit Karaca, Cengiz Gemici, Mahmut Gumus, Suleyman Buyukberber.   

Abstract

BACKGROUND/AIMS: Gastrointestinal stromal tumors (GISTs) are the most common primary mesenchymal neoplasms of the tubular gastrointestinal tract (GI). Here, we present a series of 32 patients diagnosed with a primary neoplasm in addition to GIST, from six different institutions in Turkey.
METHODOLOGY: In total, 200 patients with GIST were evaluated; 32 patients with both GISTs and other primary malignancies were identified.
RESULTS: This study included 20 men and 12 women median age 66.5 years (range 43-78). GIST was incidentally found intra-operatively in 12 of the cases. All patients underwent surgery. Detection of the GIST was synchronous in 19 cases, metachronous in 7 cases and preceded the GIST diagnosis in 6 cases. The median time before follow-up evaluation ranged from 4 to 80 months.
CONCLUSIONS: To our knowledge, no cases of GISTs co-existing with leiomyosarcoma of the spermatic cord and larynx tumors have been reported previously. The prevalence of malignancies in this subpopulation of GIST patients is significantly higher than the prevalence of malignancies in the healthy Turkish population. The high occurrence rate of additional primary malignancies in GIST patients has focused the attention of clinical oncologists on this problem, and may imply a common genetic mechanism for their etiology.

Entities:  

Mesh:

Year:  2011        PMID: 21830398

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

1.  Criminal or bystander: imatinib and second primary malignancy in GIST patients.

Authors:  Tatsuo Kanda
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

2.  The association of renal cell carcinoma with gastrointestinal stromal tumors.

Authors:  Shawn J Mendonca; Alejandro Sanchez; Kyle A Blum; Mazyar Ghanaat; Mahyar Y Kashan; Nicole Benfante; Paul Russo; Jonathan A Coleman; Aimee M Crago; A Ari Hakimi
Journal:  J Surg Oncol       Date:  2018-06-07       Impact factor: 3.454

3.  Additional malignancies in patients with gastrointestinal stromal tumors (GIST): incidence, pathology and prognosis according to a time of occurrence-based classification.

Authors:  J A Fernández; V Olivares; A J Gómez-Ruiz; B Ferri; M D Frutos; T Soria; G Torres; P Parrilla
Journal:  Clin Transl Oncol       Date:  2018-10-27       Impact factor: 3.405

4.  Metachronous gastrointestinal stromal tumor and acute leukemia after liver transplantation for cholangiocellular carcinoma: is there a link?

Authors:  Anna Mrzljak; Iva Košuta; Anita Škrtić; Ika Kardum-Skelin; Radovan Vrhovac
Journal:  Case Rep Oncol       Date:  2013-03-23

5.  Frequence, spectrum and prognostic impact of additional malignancies in patients with gastrointestinal stromal tumors.

Authors:  K Kramer; S Wolf; B Mayer; S A Schmidt; A Agaimy; D Henne-Bruns; U Knippschild; M Schwab; M Schmieder
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

6.  Synchronous and metachronous gastric gist with pancreatic adenocarcinoma: report of 2 cases and a review of literature.

Authors:  Marco Fiore; Giorgio de Stefano; Nicola Coppola; Antonio Giorgio
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

7.  Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors.

Authors:  Meng Lv; Xiao Zhang; Yanwei Shen; Fan Wang; Jiao Yang; Biyuan Wang; Zheling Chen; Pan Li; Xiaoman Zhang; Shuting Li; Jin Yang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia.

Authors:  Johanna Waidhauser; Anne Bornemann; Martin Trepel; Bruno Märkl
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

9.  Prospective observational study of imatinib therapy in Japanese patients with advanced gastrointestinal stromal tumors: long-term follow-up and second malignancy.

Authors:  Tatsuo Kanda; Takashi Ishikawa; Seiichi Hirota; Kazuhito Yajima; Shin-ichi Kosugi; Manabu Ohashi; Satoshi Suzuki; Yasuoki Mashima; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  Jpn J Clin Oncol       Date:  2012-04-21       Impact factor: 3.019

10.  Second Primary Tumors in Patients with Gastrointestinal Stromal Tumors: A Single-Center Experience.

Authors:  Murat Koçer; Sadık Muallaoğlu; Bülent Çetin; Hasan Şenol Coşkun; Nermin Karahan; Osman Gürdal
Journal:  Medicina (Kaunas)       Date:  2021-05-13       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.